Prediction of Duration of Mechanical Ventilation in Acute Hypoxemic Respiratoty Failure

NCT ID: NCT06815523

Last Updated: 2025-03-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

1241 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-02

Study Completion Date

2026-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute hypoxemic respiratory failure (AHRF) is a common cause of admission in intensive care units (ICUs) worldwide. We will assess machine learning (ML) techniques for prediction of prolonged duration (\> or = to 7 days) of mechanical ventilation (MV) in 1,241 patients enrolled in the PANDORA study in Spain. The study was registered with ClinalTrials.gov (NCT03145974). Our aim is to identify a model with the minimum number of variables that predict duration of prolonged ventilation in AHRF patients using data as early as from the first 48 hours with machine learning algorithms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acute hypoxemic respiratory failure (AHRF) is the most common cause of admission in intensive care units (ICUs) worldwide. The investigators will assess the value of machine learning (ML) techniques for prediction of prolonged duration (\> or equeal to 7 days) of mechanical ventilation (MV) in 1,241 patients enrolled in the PANDORA study in Spain. Few studies have investigated the prediction of prolonged MV in patients with AHRF.

For model training and testing, the investigators will extract data from random pateints from the first 2 days after diagnosis of AHRF. The investigators had a database with 2,000,000 anonymized and dissociated demographics and clinically relevant data from 1,241 patients with AHRF from 22 hospitals in Spain. The investigators will follow the TRIPOD guidelines for prediction models. The investigators will screen relevant collected variables using a genetic algorithm variable selection to achieve parsimony. We will use 5-fold corss-validation in the data set of patients with data at T0, T24 and T48. We will use 25% of patients randomly selected for evaluation of the model.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Hypoxemic Respiratory Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Derivation/testing cohort

The investigators will use a chort of 75% of patients, randomly selected, with data at T0, T24 and T48 after diagnosis of acute hypoxemic respiratory failure (AHRF). We will apply machine learning approaches.

Machine learning and logistic regression for the training/testing cohort and validation cohort

Intervention Type OTHER

Machine learning and logistic regression for the validation cohort

Validation hohort

we will use 25% of unseen patients, randomly selected, with data at T0, T24 and T48 after diagnosis of AHRF.

Machine learning and logistic regression for the training/testing cohort and validation cohort

Intervention Type OTHER

Machine learning and logistic regression for the validation cohort

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Machine learning and logistic regression for the training/testing cohort and validation cohort

Machine learning and logistic regression for the validation cohort

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* enotracheal intubation puls mechanical ventilation
* PaO2/FiO2 ratio \<or = 300 mmHg under MV with PEEP \>or =5 and FiO2 \>or = 0.3

Exclusion Criteria

* Brain death patients
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Universitario Dr. Negrín (Las Palmas de Gran Canaria)

UNKNOWN

Sponsor Role collaborator

Iinstituto de Salud Carlos III

UNKNOWN

Sponsor Role collaborator

Jesus Villar

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jesus Villar

Scientific Advisor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jesus Villar

Role: STUDY_DIRECTOR

Fundacion Canaria Instituto de Investigación Sanitaria de Canarias

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Dr. Negrin

Las Palmas de Gran Canaria, Las Palmas, Spain

Site Status

Hospital Universitario La Paz

Madrid, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PIFIISC24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.